Edgar Filing: KEWAUNEE SCIENTIFIC CORP /DE/

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2009

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-5286

KEWAUNEE SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)


Delaware		38-0715562
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

2700 West Front Street Statesville, North Carolina		28677-2927
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Dates File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

(Do not check if a smaller

reporting company)

Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of December 7, 2009, the registrant had outstanding 2,569,310 shares of Common Stock.

KEWAUNEE SCIENTIFIC CORPORATION

INDEX TO FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 2009


		Page Number
PART I. FINANCIAL INFORMATION		1

Item 1.	Financial Statements	1

	Consolidated Statements of Operations – Three and Six months ended October 31, 2009 and 2008	1

	Consolidated Balance Sheets October 31, 2009 and April 30, 2009	2

	Consolidated Statements of Cash Flows – Six months ended October 31, 2009 and 2008	3

	Notes to Consolidated Financial Statements	4

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	6

	Review by Independent Registered Public Accounting Firm	8

	Report of Independent Registered Public Accounting Firm	9

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	10

Item 4.	Controls and Procedures	10

PART II. OTHER INFORMATION		11

Item 4.	Submission of Matters to a Vote of Security Holders	11

Item 6.	Exhibits	11

SIGNATURE		12

Part 1. Financial Information

Item 1.

Financial Statements

Kewaunee Scientific Corporation

Consolidated Statements of Operations

(Unaudited)

(in thousands, except per share data)


	Three months ended October 31						Six months ended October 31
	2009			2008			2009			2008
Net Sales	$	27,088		$	27,732		$	53,337		$	53,127
Costs of products sold		20,878			21,713			41,363			41,757

Gross profit		6,210			6,019			11,974			11,370
Operating expenses		3,976			3,858			7,942			7,444

Operating earnings		2,234			2,161			4,032			3,926
Other expense		—			(1	)		—			(39	)
Interest expense		(39	)		(93	)		(80	)		(182	)

Earnings before income taxes		2,195			2,067			3,952			3,705
Income tax expense		751			566			1,340			1,107

Net earnings		1,444			1,501			2,612			2,598
Less: net earnings attributable to the noncontrolling interest		92			37			189			153

Net earnings attributable to Kewaunee Scientific Corporation	$	1,352		$	1,464		$	2,423		$	2,445

Net earnings per share attributable to Kewaunee Scientific Corporation stockholders
Basic	$	0.53		$	0.57		$	0.95		$	0.96
Diluted	$	0.53		$	0.57		$	0.95		$	0.95
Weighted average number of common shares outstanding (in thousands)
Basic		2,560			2,555			2,558			2,553
Diluted		2,571			2,562			2,564			2,566

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Balance Sheets

(in thousands)


	October 31, 2009			April 30, 2009
	(Unaudited)
*Assets*
Current assets:
Cash and cash equivalents	$	2,596		$	3,559
Restricted cash		461			456
Receivables, less allowance		26,660			24,526
Inventories		8,117			7,839
Deferred income taxes		311			309
Prepaid expenses and other current assets		1,389			856

Total current assets		39,534			37,545
Property, plant and equipment, at cost		40,952			39,298
Accumulated depreciation		(28,560	)		(27,929	)

Net property, plant and equipment		12,392			11,369
Deferred income taxes		339			351
Other		3,759			3,264

Total other assets		4,098			3,615

Total Assets	$	56,024		$	52,529

*Liabilities and Stockholders’ Equity*
Current liabilities:
Short-term borrowings	$	5,370		$	5,720
Current obligations under capital leases		100			220
Accounts payable		7,410			8,812
Employee compensation and amounts withheld		1,476			1,709
Deferred revenue		1,327			1,298
Other accrued expenses		2,971			904

Total current liabilities		18,654			18,663
Obligations under capital leases		177			201
Accrued employee benefit plan costs		6,371			5,406

Total Liabilities		25,202			24,270
Equity:
Common Stock		6,550			6,550
Additional paid-in-capital		711			614
Retained earnings		27,764			25,802
Accumulated other comprehensive loss		(5,308	)		(5,521	)
Common stock in treasury, at cost		(471	)		(492	)

Total Kewaunee Scientific Corporation stockholders’ equity		29,246			26,953
Noncontrolling interest		1,576			1,306

Total Equity		30,822			28,259

Total Liabilities and Equity	$	56,024		$	52,529

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)


	Six months ended October 31
	2009			2008
*Cash flows from operating activities:*
Net earnings	$	2,423		$	2,445
Adjustments to reconcile net earnings to net cash used in operating activities:
Depreciation		1,255			1,135
Bad debt provision		71			116
Provision for deferred income tax expense		10			(2	)
Decrease in prepaid income taxes		9			812
Increase in receivables		(2,205	)		(5,537	)
(Increase) decrease in inventories		(278	)		118
Increase in prepaid pension cost		—			(148	)
Increase in accounts payable and other accrued expenses		432			698
Increase in deferred revenue		29			707
Other, net		327			(847	)

Net cash provided by (used in) operating activities		2,073			(503	)
*Cash flows from investing activities:*
Capital expenditures		(2,278	)		(679	)
Increase (decrease) in restricted cash		(5	)		72

Net cash used in investing activities		(2,283	)		(607	)
*Cash flows from financing activities:*
Dividends paid		(461	)		(408	)
Decrease (increase) in short-term borrowings		(350	)		415
Payments on capital leases		(144	)		(192	)
Purchase of treasury stock		(114	)		(198	)
Proceeds from exercise of stock options (including tax benefit)		135			276

Net cash used in financing activities		(934	)		(107	)
Effect of exchange rate changes on cash		181			(285	)

*Decrease in cash and cash equivalents*		(963	)		(1,502	)
*Cash and cash equivalents, beginning of period*		3,559			3,784

*Cash and cash equivalents, end of period*	$	2,596		$	2,282

See accompanying notes to consolidated financial statements

Kewaunee Scientific Corporation

Notes to Consolidated Financial Statements

(unaudited)

A. Financial Information

The unaudited interim consolidated financial statements of Kewaunee Scientific Corporation (the “Company” or “Kewaunee”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s 2009 Annual Report to Stockholders. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

The preparation of the consolidated financial statements requires management to make certain estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates. In preparing these interim consolidated financial statements, we have reviewed and considered for disclosure all significant events occurring through December 11, 2009, the date of financial statement issuance.

B. Inventories

Inventories consisted of the following (in thousands):


	October 31, 2009		April 30, 2009
Finished products	$	1,772	$	1,756
Work in process		1,534		1,461
Raw materials		4,811		4,622

	$	8,117	$	7,839

For interim reporting, LIFO inventories are computed based on year-to-date quantities and interim changes in price levels. Changes in quantities and price levels are reflected in the interim consolidated financial statements in the period in which they occur.

C. Comprehensive Income

A reconciliation of net earnings and total comprehensive income for the three and six months ended October 31, 2009 and 2008 is as follows (in thousands):


	Three months ended October 31, 2009		Three months ended October 31, 2008
Net earnings	$	1,352	$	1,464
Change in cumulative foreign currency translation adjustments		109		(588	)

Total comprehensive income	$	1,461	$	876


	Six months ended October 31, 2009		Six months ended October 31, 2008
Net earnings	$	2,423	$	2,445
Change in cumulative foreign currency translation adjustments		213		(724	)

Total comprehensive income	$	2,636	$	1,721

Assets and liabilities for the Company’s foreign subsidiaries are translated at exchange rates prevailing on the balance sheet date. Revenues and expenses are translated at weighted average exchange rates prevailing during the period and any resulting translation adjustments are reported separately in stockholders’ equity.

D. Segment Information

The following table provides financial information by business segments for the three and six months ended October 31, 2009 and 2008 (in thousands):


	Domestic Operations		International Operations		Corporate			Total
Three months ended October 31, 2009
Revenues from external customers	$	24,713	$	2,375	$	—		$	27,088
Intersegment revenues		271		310		(581	)		—
Operating earnings (loss) before income taxes		2,900		206		(911	)		2,195
Three months ended October 31, 2008
Revenues from external customers	$	23,785	$	3,947	$	—		$	27,732
Intersegment revenues		851		21		(872	)		—
Operating earnings (loss) before incomes taxes		2,693		309		(935	)		2,067
Six months ended October 31, 2009
Revenues from external customers	$	48,071	$	5,266	$	—		$	53,337
Intersegment revenues		691		417		(1,108	)		—
Operating earnings (loss) before incomes taxes		5,445		509		(2,002	)		3,952
Six months ended October 31, 2008
Revenues from external customers	$	44,798	$	8,329	$	—		$	53,127
Intersegment revenues		1,637		25		(1,662	)		—
Operating earnings (loss) before incomes taxes		4,732		723		(1,750	)		3,705

E. Defined Pension Plans

The Company has non-contributory defined benefit pension plans covering substantially all salaried and hourly employees. These plans were amended as of April 30, 2005, no further benefits have been, or will be, earned under the plans, subsequent to the amendment date, and no additional participants will be added to the plans. No contributions were paid to the plans during the six months ended October 31, 2009, and the Company does not expect any contributions to be paid to the plans during the remainder of the current fiscal year.

Pension expense (income) consisted of the following (in thousands):


	Three months ended October 31, 2009			Three months ended October 31, 2008
Service cost	$	-0-		$	-0-
Interest cost		245			220
Expected return on plan assets		(234	)		(339	)
Recognition of net loss		187			31

Net periodic pension expense (income)	$	198		$	(88	)


	Six months ended October 31, 2009			Six months ended October 31, 2008
Service cost	$	-0-		$	-0-
Interest cost		475			448
Expected return on plan assets		(469	)		(676	)
Recognition of net loss		347			80

Net periodic pension expense (income)	$	353		$	(148	)

F. Credit Arrangement

In July 2009, the Company amended its unsecured revolving credit facility to extend the facility’s expiration date to July 31, 2012, and modify the variable rate component of the interest calculation. Monthly interest payments under the facility, as amended, are payable calculated at the 30-day LIBOR Market Interest Rate plus a variable rate ranging from 1.575% to 2.175%.

In July 2009, the Company entered into an interest rate SWAP agreement whereby the interest rate payable by the Company on $2 million of outstanding advances under the revolving credit facility will effectively convert to a fixed interest rate of 3.9% for the period beginning August 3, 2009, and ending August 1, 2012. The Company entered into this interest rate swap to mitigate future interest rate risk associated with advances under the credit facility.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company’s 2009 Annual Report to Stockholders contains management’s discussion and analysis of financial condition and results of operations at and for the year ended April 30, 2009. The following discussion and analysis describes material changes in the Company’s financial condition since April 30, 2009. The analysis of results of operations compares the three and six months ended October 31, 2009 with the comparable period of the prior fiscal year.

Results of Operations

Sales for the three months ended October 31, 2009 were $27,088,000, a decrease of 2% from sales of $27,732,000 in the same period last year. Sales from Domestic Operations were $24,713,000, an increase of 4% from the prior year period. Sales from International Operations were $2,375,000, a decrease of 40% from the prior year period.

Sales for the six months ended October 31, 2009 were $53,337,000, a slight increase from sales of $53,127,000 in the same period last year. Sales from Domestic Operations were $48,071,000, an increase of 7% from the prior year period. Sales from International Operations were $5,266,000, a decrease of 37% from the prior year period. The decline in international operations sales for both the three and six month periods resulted from customer changes in their product delivery dates. The order backlog at October 31, 2009 was $65.2 million, as compared to a backlog of $62.7 million at April 30, 2009 and $61.6 million at October 31, 2008.

The gross profit margin for the three months ended October 31, 2009 was 22.9% of sales, as compared to 21.7% of sales in the comparable quarter of the prior year. The gross profit margin for the six months ended October 31, 2009 was 22.4% of sales, as compared to 21.4% of sales in the comparable quarter of the prior year. The increases in gross profit margin percentages were primarily due to increased manufacturing efficiencies, savings from alternative sources of raw materials and components, and other cost improvements.

Operating expenses for the three months ended October 31, 2009 were $3,976,000, or 14.7% of sales, as compared to $3,858,000, or 13.9% of sales, in the comparable period of the prior year. Operating expenses for the six months ended October 31, 2009 were $7,942,000, or 14.9% of sales, as compared to $7,444,000, or 14.0% of sales, in the comparable period of the prior year. The increase in operating expenses for the current quarter was primarily due to an increase of $286,000 in pension expense, partially offset by a decrease in compensation expense of $127,000. The increase in operating expenses for the current year six-month period was primarily due to an increase of $501,000 in pension expense, partially offset by a decrease in compensation expense of $76,000.

Operating earnings were $2,234,000 and $4,032,000 for the three and six months ended October 31, 2009. This compares to operating earnings of $2,161,000 and $3,926,000 for the comparable periods of the prior year.

Interest expense was $39,000 and $80,000 for the three and six months ended October 31, 2009, respectively, as compared to $93,000 and $182,000 for the comparable periods of the prior year. The decrease in interest expense for the current year periods resulted from lower interest rates on advances.

There was no other income and other expense in the three and six months ended October 31, 2009, respectively, as compared to income of $1,000 and $39,000 for the comparable periods of the prior year.

Income tax expense of $751,000 and $1,340,000 was recorded for the three and six months ended October 31, 2009, respectively, as compared to income tax expense of $566,000 and $1,107,000 recorded for the comparable periods of the prior year. The effective tax rates were 34.2% and 33.9% for the three and six months ended October 31, 2009, respectively, and were 27.4% and 29.9% for the three and six months ended October 31, 2008. The effective tax rates for each of the three and six month periods differs from the statutory rate primarily due to the impact of varying income tax rates on income earned by the Company’s foreign subsidiaries. In addition to this factor, the effective tax rates for all the periods were favorably impacted by earned state and federal tax credits. The increase in the effective tax rates in the current year periods as compared to the prior year periods resulted primarily from a lower portion of earnings in the current year periods from subsidiaries located in geographic locations with lower income tax rates.

Minority interests relate to minority shareholders’ interest in the Company’s two subsidiaries that are not 100% owned by the Company. Minority interests reduced net earnings by $92,000 and $189,000 for the three and six months ended October 31, 2009, as compared to reductions of $37,000 and $153,000 for the comparable periods of the prior year. The decrease in minority interests in the current period was related to lower earnings of the two subsidiaries.

Net earnings were $1,352,000, or $0.53 per diluted share, and $2,423,000, or $0.95 per diluted share, for the three and six months ended October 31, 2009. Net earnings were $1,464,000, or $0.57 per diluted share, and $2,445,000, or $0.95 per diluted share, for the three and six-months ended October 31, 2008.

Liquidity and Capital Resources

Historically, the Company’s principal sources of liquidity have been funds generated from operations, supplemented as needed by short-term borrowings under the Company’s revolving credit facility. Additionally, certain machinery and equipment are financed by non-cancellable operating leases or capital leases. The Company believes that these sources will be sufficient to support ongoing business requirements, including capital expenditures through the current fiscal year.

The Company had working capital of $20.9 million at October 31, 2009, compared to $18.9 million at April 30, 2009. The ratio of current assets to current liabilities was 2.1-to-1.0 at October 31, 2009, compared to 2.0-to-1.0 at April 30, 2009. At October 31, 2009, advances of $5,370,000 were outstanding under the Company’s bank revolving credit facility, as compared to advances of $5,720,000 outstanding as of April 30, 2009.

The Company’s operations provided cash of $2,073,000 during the six months ended October 31, 2009. Cash was primarily provided from earnings, which was partially offset by increased accounts receivable of $2,205,000. The Company’s operations used cash of $503,000 during the six months ended October 31, 2008. Cash was primarily used to fund an increase of $5,537,000 in accounts receivable, which was partially offset by cash provided from operating earnings.

During the six months ended October 31, 2009, net cash of $2,283,000 was used by investing activities, primarily for capital expenditures. This compares to the use of $607,000 for investing activities in the comparable period of the prior year, primarily for capital expenditures.

The Company’s financing activities used cash of $934,000 during the six months ended October 31, 2009. Cash used included cash dividends paid of $461,000, payments on obligations of capital leases of $144,000, and purchases of treasury stock of $114,000 and $350,000 for a reduction in short-term borrowing, partially offset by $135,000 in proceeds received from the exercise of stock options. Financing activities used cash of $107,000 in the same period for the prior year, which included $408,000 for cash dividends, $192,000 for payments on obligations of capital leases, and $198,000 for the purchase of treasury stock, partially offset by increased short-term borrowings of $415,000 and $276,000 received from the exercise of stock options.

Outlook for Third Quarter of Fiscal Year 2010

While the Company’s ability to predict future demand for its products continues to be limited given, among other general economic factors affecting the Company and its markets, the Company’s role as subcontractor or supplier to dealers for subcontractors, the Company expects the third quarter of fiscal year 2010 to be profitable. In addition to general economic factors affecting the Company and its markets, demand for its products is also dependent upon the number of laboratory construction projects planned and/or current progress in projects already under construction.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain statements in this report constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company’s operations, markets, products, services, and prices, as well as prices for certain raw materials and energy. The cautionary statements made pursuant to the Reform Act herein and elsewhere by the Company should not be construed as exhaustive. The Company cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. In addition, readers are urged to consider statements that include the terms “believes”, “belief”, “expects”, “plans”, “objectives”, “anticipates”, “intends” or the like to be uncertain and forward-looking. Over time, the Company’s actual results, performance or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by the Company’s forward-looking statements, and such difference might be significant and harmful to stockholders’ interests. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of the Company’s 2009 Annual Report on Form 10-K.

REVIEW BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

A review of the interim consolidated financial information included in this Quarterly Report on Form 10-Q for each of the three and six month periods ended October 31, 2009 and October 31, 2008 has been performed by Cherry, Bekaert & Holland, L.L.P., the Company’s registered public accounting firm. Their report on the interim consolidated financial information follows.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have reviewed the accompanying consolidated balance sheets of Kewaunee Scientific Corporation and its subsidiaries (the “Company”) as of October 31, 2009, and the related consolidated statements of operations for the three month and six month periods ended October 31, 2009 and 2008 and the related consolidated statements of cash flows for the six-month periods ended October 31, 2009 and 2008. These interim consolidated financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the interim consolidated financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of April 30, 2009, and the related statements of operations, of stockholders’ equity and of cash flows for the year then ended (not presented herein) and in our report dated July 10, 2009, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of April 30, 2009 is fairly stated in all material respects in relation to the consolidated financial statement from which it has been derived.

/s/ Cherry, Bekaert & Holland, L.L.P.

Charlotte, North Carolina

December 11, 2009

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

There are no material changes to the disclosures made on this matter in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2009.

Item 4.

Controls and Procedures

(a) Evaluation of disclosure controls and procedures

An evaluation was performed under the supervision and the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of October 31, 2009. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of October 31, 2009, the Company’s disclosure controls and procedures were adequate and effective and designed to ensure that all material information required to be filed in this quarterly report is made known to them by others within the Company and its subsidiaries.

(b) Changes in internal controls

There was no significant change in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 4.

Submission of Matters to a Vote of Security Holders

The Company’s Annual Meeting of Stockholders was held on August 26, 2009. Information regarding the results of this meeting are incorporated by reference from Item 4 of Part II of the Company’s Report on Form 10-Q for the three months ended July 31, 2009.

Item 6.

Exhibits



31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	KEWAUNEE SCIENTIFIC CORPORATION (Registrant)

Date: December 11, 2009	By	/s/ D. Michael Parker
		D. Michael Parker (As duly authorized officer and Senior Vice President, Finance and Chief Financial Officer)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents